Compared to non-specific IgE, CSPG4 IgE significantly decreased subcutaneous melanoma tumor volume and weight, and lung lesional growth, in healthy volunteer and melanoma patient-derived immune cell-engrafted mice. This evidence concerns the gene CSPG4 and neoplasm.